Michael Raab - 05 Jun 2025 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
05 Jun 2025
Transactions value $
$0
Form type
4
Filing time
06 Jun 2025, 16:58:48
Previous filing
22 May 2025
Next filing
25 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
RAAB MICHAEL Director 47 HULFISH STREET, PRINCETON /s/ Christian Formica, Attorney-in-Fact 06 Jun 2025 0001321402

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award $0 +20.4K +21.39% $0.00 116K 05 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +74.9K $0.00 74.9K 05 Jun 2025 Common Stock 74.9K $5.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
F2 One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.